Study guide
1.2 Comparing Evidence-Based Design (EBD) and Evidence-Based Medicine (EBM)
Evidence-Based Design Accreditation EDAC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Foundations of Evidence-Based Design
1.1 Definition, History & Core Principles of Evidence-Based Design 1.2 Comparing Evidence-Based Design (EBD) and Evidence-Based Medicine (EBM) 1.3 The Eight-Step EBD Process Framework 1.4 Who Benefits from EBD & Which Outcomes It Can Influence
2 Chapter 2: Healthcare Context, Systems Thinking & Leadership
2.1 Macro Healthcare Trends, Demographics & Economic Drivers 2.2 The Healthcare Delivery System: Care Settings, Hospital Types & Networks 2.3 The Systems-Based Approach (Formerly the Environment of Care) 2.4 Organizational Culture, Culture Change & Cross-Cultural Design 2.5 Healthcare Stakeholders, Facility Users & Governance Roles 2.6 Executive Leadership, Project Lifecycle Changes & Succession Planning
3 Chapter 3: Healing Environments, Theory & the EDAC Credential
3.1 Healing Environments, Psycho-Neuro-Immunology & Stress Reduction 3.2 Positive Distractions, Biophilia & Roger Ulrich Landmark Research 3.3 Integrative Medicine & Designing Healing and Therapeutic Environments 3.4 Healthcare Workplace Design, Staff Retention & Fatigue Reduction 3.5 Professional Responsibility, Healthcare Outcomes & the EDAC Credential
4 Chapter 4: Research Fundamentals & Evidence Sources
4.1 The Role of Research in Healthcare Architecture & Design 4.2 Types of Evidence: Internal vs. External Evidence 4.3 Literature Searches, Academic Databases & Search Strategies 4.4 Screening, Extracting & Synthesizing Healthcare Design Literature
5 Chapter 5: Evidence Hierarchies & Critical Appraisal
5.1 The Hierarchy of Evidence: Systematic Reviews to Expert Opinion 5.2 Internal Validity, External Validity & Reliability in EBD 5.3 Research Bias, Confounding Factors & Threat Mitigation 5.4 Step 3: The Critical Interpretation & Appraisal Process
6 Chapter 6: Research Methodologies, Data Analysis & the Research Plan
6.1 Quantitative Research Designs, Metrics & Statistical Significance 6.2 Qualitative Methods, Behavioral Observation & Spatial Mapping 6.3 Mixed Methods, Data Triangulation & Research-to-Design Translation 6.4 The Research Process: Research Questions, Research Plans, Ethics & Reporting
7 Chapter 7: Project Setup & Predesign
7.1 Project Setup: Early Capital Planning, Context & Culture, and the EBD Budget 7.2 Step 1: Defining Evidence-Based Vision, Goals & Objectives 7.3 Participative Design, Charrettes & Advisory Councils 7.4 Functional Programming, Adjacencies & Flow Analysis
8 Chapter 8: Hypotheses, Baselines & the Business Case
8.1 Step 5: Formulating Rigorous, Testable EBD Hypotheses 8.2 Step 6: Planning & Collecting Baseline Performance Measures 8.3 The Business Case for EBD: Capital Costs vs. Operational Life-Cycle 8.4 Prioritizing Design Interventions Under Budget Constraints
9 Chapter 9: Designing for Safety: Risk Assessment, Infection, Falls & Medication Safety
9.1 Attributes of a Safe Environment & the Safety Risk Assessment 9.2 Infection Control, Single-Bed Rooms & Hand-Hygiene Design 9.3 Fall Prevention, Same-Handed Rooms & Bathroom Adjacencies 9.4 Medication Safety, Decentralized Nursing Stations & Workflow
10 Chapter 10: Design Phase: Environmental Factors, Concepts & Mock-Ups
10.1 Healthcare Acoustics, Noise Reduction & Sound Absorption 10.2 Circadian Lighting, Natural Daylight & Visual Performance 10.3 Step 4: Creating and Innovating Evidence-Based Design Concepts 10.4 Step 4 Prototyping: Mock-Ups, Simulation & Iterative Evaluation
11 Chapter 11: Construction, Commissioning & Activation
11.1 Step 7: Monitoring Implementation Fidelity & Guarding EBD Intent 11.2 Commissioning: Verifying the Building Meets EBD Intent Before Occupancy 11.3 Activation Readiness, Transition Planning & Finalizing the POE Research Plan
12 Chapter 12: Post-Occupancy Evaluation & Knowledge Sharing
12.1 Step 8: Post-Occupancy Evaluation Methodology & Timing 12.2 Executing the POE Research Plan, Independent Evaluation & Finalizing the Business Case 12.3 Analyzing POE Data, Isolating Environmental Effects & Mixed Outcomes 12.4 Knowledge Dissemination, Peer Review & Continuous Improvement
1.2 Comparing Evidence-Based Design (EBD) and Evidence-Based Medicine (EBM)
Key Takeaways Explain This Topic AI
Evidence-Based Medicine (EBM), developed in the late 1980s and 1990s by David Sackett, Gordon Guyatt, and colleagues at McMaster University, integrates clinical expertise with the best external research evidence.
EBD borrows EBM's decision logic: combine the best available research evidence with professional design expertise and client, patient, and staff values.
Unlike many drug trials in EBM, EBD studies of whole buildings usually cannot use double-blind randomized placebo-controlled trials, because occupants can see and experience the physical environment.
Buildings are large, long-lived capital commitments that cannot be quickly discontinued like a drug, which raises the stakes of getting design decisions right before construction.
Healthcare facilities are open systems full of confounding variables (acuity shifts, staffing ratios, protocols), so EBD research relies heavily on quasi-experimental and mixed-method designs.
Last updated: September 2026
Comparing Evidence-Based Design (EBD) and Evidence-Based Medicine (EBM)
To understand the intellectual foundation of Evidence-Based Design (EBD), one must examine its parent discipline: Evidence-Based Medicine (EBM) . During the late 20th century, both healthcare delivery and healthcare architecture underwent parallel paradigms shifts, abandoning unexamined traditions in favor of rigorous, empirical inquiry.
However, while EBD draws inspiration from EBM's epistemological framework, the physical, financial, and ethical realities of the built environment demand fundamentally different methodological approaches.
The Origins and Triad of Evidence-Based Medicine (EBM)
Evidence-Based Medicine emerged in the late 1980s and early 1990s, led by Dr. David Sackett , Gordon Guyatt, and colleagues at McMaster University in Ontario, Canada.
In his classic 1996 editorial in the British Medical Journal , Dr. Sackett articulated the definitive definition:
"Evidence-based medicine is the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients. The practice of evidence-based medicine means integrating individual clinical expertise with the best available external clinical evidence from systematic research."
The EBM Tripartite Model
Sackett and colleagues described EBM as a three-part integration (later versions explicitly added patient values). Clinical decisions must synthesize three distinct elements:
Best Available External Clinical Evidence: Findings from clinically relevant research, often conducted through randomized controlled trials (RCTs), systematic reviews, and meta-analyses.
Individual Clinical Expertise: The proficiency, clinical judgment, and diagnostic acumen acquired by clinicians through years of practice.
Patient Values and Expectations: The unique preferences, cultural beliefs, personal priorities, and ethical expectations each patient brings to a clinical encounter. EBM TRIAD EBD TRIAD
- ┌───────────────────────┐ ┌───────────────────────┐
- │ Best Clinical Evidence│ │Best Research Evidence │
- └──────────┬────────────┘ └──────────┬────────────┘
- │ │
- ───────┴─────── ───────┴───────
- / \ / \
- ┌────────────┐ ┌─────────────┐ ┌────────────┐ ┌─────────────┐
- │ Clinical │ │ Patient │ │Practitioner│ │ Client/User │
- │ Expertise │ │ Values │ │ Expertise │ │ Values │
- └────────────┘ └─────────────┘ └────────────┘ └─────────────┘
- The EBD Parallel: A Shared Epistemological Framework
Evidence-Based Design directly adopts this tripartite decision-making philosophy. An evidence-based architect or designer does not mechanically copy research findings into a floor plan. Instead, EBD requires the deliberate integration of:
Best Available Research Evidence: Empirical data from peer-reviewed journals, post-occupancy evaluations, and institutional clinical metrics.
Practitioner Expertise & Design Acumen: The architectural team's synthesis of building codes, spatial syntax, aesthetic composition, constructability, and engineering systems.
Client, Patient, and Staff Values: The healthcare organization's strategic mission, operational culture, clinical care delivery model, and patient demographic needs.
Commonalities Between EBM and EBD
Rejection of Unexamined Dogma: Both disciplines reject decisions justified solely by "this is how we have always done it."
Commitment to Systematic Inquiry: Both require rigorous search strategies, critical appraisal of methodological quality, and transparent documentation of rationale.
Use of Evidence Hierarchies: Both organize evidence along a gradient of rigor, recognizing that systematic reviews and controlled studies provide stronger inferential validity than anecdotal opinions.
Continuous Learning Loop: Both view practice as an ongoing cycle of hypothesis generation, intervention, outcome measurement, and dissemination.
Crucial Differences: Built Environment vs. Clinical Therapeutics
Despite shared philosophical roots, EBD encounters structural, methodological, and physical realities that make it impossible to simply mirror EBM. Understanding these differences helps you reason through scenario questions about why EBD research looks different from clinical trials.
Dimension Evidence-Based Medicine (EBM) Evidence-Based Design (EBD)
Primary Intervention Biochemical, pharmaceutical, surgical, or behavioral therapy Physical, spatial, acoustic, lighting, or technological environment
Gold Standard Research Design Double-blind randomized placebo-controlled trial (RCT) Quasi-experimental, prospective cohort, pre/post POE, interrupted time-series
Blinding Feasibility Often feasible; patient and clinician can receive identical-looking placebos Rarely feasible; occupants immediately perceive spatial changes
Intervention Scale & Cost Micro-scale (pill, injection); low per-unit cost Macro-scale (building, wing); large, long-lived capital investment
Reversibility Immediate; clinician halts medication upon adverse reaction Highly irreversible; concrete, steel, and MEP systems are fixed for decades
Facility / Asset Life Cycle Days, weeks, or months per therapeutic regimen 30 to 50+ years of physical and operational building life
Confounding Variables Controllable via strict clinical inclusion/exclusion criteria Ubiquitous; operational changes, staffing shifts, patient acuity variations occur concurrently
Intervention Isolation High; single active chemical compound isolated against placebo Low; complex bundling (single room bundles daylight, acoustics, sink placement, and airflow)
Team Composition Physicians, clinical researchers, biostatisticians, epidemiologists Multidisciplinary: architects, interior designers, engineers, C-suite, nurses, facility managers
Feedback Loop Timing Rapid; lab markers and clinical endpoints measured in days/months Long; often several years from predesign programming to post-occupancy evaluation (POE)
1. The Impossibility of Double-Blind Placebo RCTs
In pharmacological EBM, the double-blind randomized controlled trial (RCT) reigns supreme because neither the patient nor the administering physician knows who receives the active drug versus an inert sugar pill. This eliminates placebo effects and observer bias.
In healthcare architecture, blinding is rarely possible . A patient and nurse immediately perceive whether a room is private or semi-private, whether it has an expansive window looking out on nature or is windowless, and whether the floor is carpeted or vinyl.
Furthermore, constructing an "inert placebo hospital" is physically, financially, and ethically unrealistic. Intentionally placing acutely ill patients in substandard, hazardous, or sham physical layouts to serve as a negative control violates fundamental bioethical standards (such as the Belmont Report and Declaration of Helsinki).
2. Intervention Bundling and Confounding Variables
In medical science, researchers isolate a single independent variable (e.g., administering 10 mg of a statin versus placebo) while holding diet and other medications constant.
In healthcare architecture, spatial interventions are inherently bundled . When a hospital opens a replacement intensive care unit, multiple environmental changes occur simultaneously:
Acuity-adaptable private rooms replace multi-bed wards.
High-performance acoustic ceiling tiles (NRC 0.90) replace hard drywall.
Tunable circadian LED lighting replaces static fluorescent fixtures.
Dedicated hand-hygiene sinks are positioned directly in the line of sight upon entry.
Decentralized nursing alcoves replace a single centralized nurses' station.
If the hospital experiences a 30% decline in delirium and a 25% drop in central-line infections, which specific design element caused the improvement? Did delirium drop because of circadian lighting, acoustic attenuation, or private room privacy?
Furthermore, physical moves almost always coincide with operational confounding variables : new electronic health record (EHR) installations, revised nurse-to-patient staffing ratios, updated clinical infection bundles, and altered visitor policies. EBD researchers therefore use comparison units, time-series designs, and statistical adjustment to help separate environmental effects from operational shifts.
3. Capital Permanence and the Long Feedback Loop
A physician who prescribes a pharmaceutical agent that causes an adverse allergic reaction can discontinue the drug within minutes. The therapeutic course is agile and low-risk.
Conversely, a new hospital tower represents a capital commitment that can reach hundreds of millions of dollars. Once the foundations are poured, the structure erected, and the medical gas risers installed, the facility is typically expected to stay in service for decades .
A design mistake—such as installing slippery flooring that precipitates patient falls, or positioning nurse stations with poor sightlines to patient beds—persists for decades, generating ongoing operational costs, staff injuries, and clinical hazards. This massive permanence underscores why pre-construction research, rigorous prototyping, and mock-up simulations are critical in EBD.
4. Interdisciplinary Team Dynamics & The Vocabulary Gap
In EBM, decisions are made predominantly within a shared clinical culture: physicians, clinical pharmacologists, and nurses communicate using standardized medical terminology (e.g., p -values, confidence intervals, odds ratios, hazard rates).
In EBD, the decision-making body is radically interdisciplinary, bringing together stakeholders who operate in completely different paradigms:
Architects & Interior Designers: Speak of sightlines, spatial syntax, daylight harvesting, materiality, and biophilia.
MEP Engineers: Focus on air changes per hour (ACH), static pressure, duct static, and filtration efficiency (MERV ratings).
Hospital C-Suite (CFO, COO, CEO): Focus on debt service, capital allocation, EBITDA, market share, and operational payback periods.
Clinical Leadership (CNO, CMO, Infection Preventionists): Focus on nurse burnout, workflow fatigue, nosocomial infection rates, and CMS reimbursement penalties.
Facility Directors: Focus on maintainability, lifecycle durability, energy efficiency, and operational cleaning protocols.
An essential role of the EDAC-certified professional is acting as an interdisciplinary translator , bridging the vocabulary gap between clinical epidemiology and architectural design.
Adapting the Hierarchy of Evidence in EBD
EBM ranks evidence by how well a study design protects against bias: systematic reviews and randomized trials near the top, expert opinion near the bottom. Because true randomized trials of whole buildings are rarely possible, EBD practitioners apply the same logic to the designs that are feasible:
Relative Strength Typical EBD Evidence Why
Stronger Systematic reviews; randomized trials of small, modular interventions; quasi-experimental field studies with comparison units or long time series Structured comparison and control of alternative explanations
Moderate Correlational and cohort studies (for example, Ulrich's 1984 matched-pair study) Show associations, but unmeasured confounders remain possible
Weaker Uncontrolled single-site POEs, case studies, expert opinion, manufacturer claims Useful for ideas and hypotheses, weak for proving cause
Published hierarchies differ in how many levels they use; the principle—not a specific numbering scheme—is what matters. Chapter 5 works through a detailed hierarchy and how to appraise each study type.
Professional Responsibility in Healthcare Design
In clinical medicine, the Hippocratic Oath establishes a sacred duty: Primum non nocere ("First, do no harm").
Healthcare architects, interior designers, and facility planners carry a comparable responsibility. Because physical environments directly influence whether patients contract fatal infections, fall while attempting to reach unassisted toilets, or suffer medication errors caused by acoustic distractions, design professionals carry a moral and fiduciary responsibility to base decisions on the most credible scientific evidence available.
Tip
EXAM TIP: EBD Does Not Eliminate Design Creativity
A common misconception is the claim that Evidence-Based Design replaces architectural creativity with rigid, formulaic rules.
Just as Evidence-Based Medicine does not replace a physician's diagnostic intuition or clinical art, EBD does not stifle design creativity. Rather, EBD establishes the empirical boundary conditions and performance targets within which designers innovate creative, contextually sensitive, and aesthetically inspiring healing environments.